Linda Llewelyn - Jun 1, 2022 Form 4 Insider Report for Health Catalyst, Inc. (HCAT)

Role
Chief People Officer
Signature
/s/ Daniel Orenstein, as Attorney-in-Fact
Stock symbol
HCAT
Transactions as of
Jun 1, 2022
Transactions value $
-$12,095
Form type
4
Date filed
6/3/2022, 05:46 PM
Previous filing
May 18, 2022
Next filing
Jun 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCAT Common Stock Tax liability -$11.6K -818 -1.36% $14.24 59.4K Jun 1, 2022 Direct F1, F2
transaction HCAT Common Stock Tax liability -$449 -30 -0.05% $14.95 59.3K Jun 1, 2022 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
F2 Represents the weighted average sale price of the shares sold ranging from $13.91 to $14.90 per share, inclusive.
F3 Represents the weighted average sale price of the shares sold ranging from $14.91 to $15.07 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3).